Onyx Pharmaceuticals Announces 2013 Updates and Reviews 2012 Achievements at J.P. Morgan Healthcare Conference

[at noodls] – Kyprolisâ„¢ (carfilzomib) for Injection Net Sales Exceed $62 Million for 2012 South San Francisco, CA. – Jan. 07, 2013 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today reviewed 2012 accomplishments and announced … more

View todays social media effects on ONXX

View the latest stocks trending across Twitter. Click to view dashboard

See who ONYX is hiring next, click here to view